Start-Up NoNO Hopes to Get FDA's Yes for Stroke Drug
By Anette Breindl
Tuesday, March 6, 2012
The statistics on stroke are enough to make the most hard-boiled drug developer cry. "Over a thousand treatments that have been developed in cells and in rodents have failed," Michael Tymianski told BioWorld Today.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.